16 окт. 2024 г. · It was joined by eight others in 2023 and another, Simlandi (adalimumab-ryvk), in May 2024. Related Content ...

4 сент. 2024 г. · For April 2024, about 60% of all new Humira prescriptions were for the Cordavis product with a list price that's 81% lower than Humira's list ...

Simlandi became the 10th FDA-approved Humira biosimilar in February 2024. It's the first high-concentration and citrate-free interchangeable Humira biosimilar.

24 окт. 2024 г. · Adalimumab (Humira) Biosimilars Pipeline Review 2024: A Recombinant Human IgG1 mAb - Drug Code/INN, Target(s)/MoA, Class of Compound, Territory ...

30 июл. 2024 г. · AbbVie's Humira (adalimumab) has retained more than 80% of patients in the last year (Q3/2023 to Q2/2024), despite the availability of nine ...

6 авг. 2024 г. · Biosimilar switching was uncommon during 2023, but increased significantly in 2024. · The CVS formulary change to remove bio-originator Humira ...

16 янв. 2024 г. · In January 2024, CVS announced it would remove Humira from most of its commercial formularies and replace it with biosimilars in April 2024. CVS ...

10 мая 2024 г. · Humira marks the first specialty drug with biosimilars, here is what you need to know about the most recent developments in this space.

4 сент. 2024 г. · In 2024 to date, that number increased to 14%, including biosimilars and the Humira co-promotion. Nevertheless, Humira continues to make up 86% ...

2 апр. 2024 г. · The expected lost savings from Humira use is expected to grow in 2024 with continued use. Continued Humira use cost patients, employers, and ...